Sonali S. Shelake

Unveiling the Research Landscape of Triazole-based Aromatase Inhibitors in Breast Cancer: Bibliometric Insights

Breast cancer remains a leading cause of death among women, with one life lost approximately every 13 minutes. Postmenopausal women are particularly susceptible to Estrogen Receptor-positive (ER+) breast cancer. Aromatase inhibitors, including letrozole, exemestane, and anastrozole, suppress estrogen synthesis in p...